Dental Cement Market Size Worth $2.3 Billion By 2026

The global dental cement market size is expected to reach USD 2.3 billion by the end of 2026, according to a new report by Grand View Research, Inc., growing at CAGR of 6.3%. Increasing incidence of dental cavities & other dental diseases and introduction of new formulations are major drivers of the market.

Unhealthy eating & drinking habits, plaque formation, poor oral hygiene, fluoride deficiency, and disorders such as heartburn & dry mouth are some of the major predisposing factors. These factors have resulted in an increase in the number of dental procedures. For instance, according to an article published by PubMed, individuals who consume one sugary drink occasionally are at an increased risk of dental caries and tooth loss by nearly 44% as compared to ones who do not consume any.

Moreover, advancements in these cements and material technology have led to introduction of more durable and stronger cements, fueling growth. For instance, resin-modified ionomer cement demonstrated improved adhesion, higher tensile strength, and reduced post-cementation sensitivity when compared to conventional glass ionomer.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/dental-cement-market

Further key findings from the report suggest:

  • Resin-based segment is anticipated to grow considerably over the forecast period, due to increasing popularity of self-adhesive resin cements that have wide range of.
  • Rising adoption of cosmetic dental procedures has resulted in increased demand for tooth colored restorations by patients, thus indirectly boosting market demand for resin cement.
  • Relatively high disposable income in developed economies is one of the major reasons for the growing demand for cosmetic dental procedures
  • Glass ionomer held a substantial market share in 2018. This can be attributed to the fluoride release and recharging abilities of this cement, aiding prevention of dental caries
  • The permanent segment is expected to lead in the coming years owing to features such as better aesthetics, excellent resistance, good compatibility with dental tissues, and insolubility in oral fluids or saliva
  • Restoration segment is anticipated to grow substantially in the future due to the growing number of ceramic restorations procedures
  • North America held a dominant share of the dental cement market due to well-established medical facilities, presence of skilled professionals, and extensive research activities
  • Some of the key players are 3M Company; Ivoclar Vivadent AG; Dentsply Sirona; Danaher Corporation; SHOFU Dental GmbH; BISCO, Inc.; and Medental International, Inc.

Traditional Wound Management Market Worth $7.18 Billion By 2026

The global traditional wound management market size is expected to reach USD 7.18 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 3.6% during the forecast period. Growing incidence of chronic diseases, increasing number of accidents, and rising number of ambulatory surgical centers are some of the key factors driving the market.

Global increase in incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is one of the key factors driving market growth. Factors such as, adoption of unhealthy & sedentary lifestyles, alcohol consumption, and smoking are majorly contributing toward rise in prevalence of non-communicable diseases. Cancer has been a global healthcare burden as it is one of the leading causes of death. Most surgical wounds after cancer surgery are relatively large in size and deep, producing exudate, which requires routine management. The wound care products such as bandage, medical tapes, and gauze help manage large wounds, significantly reducing the risk of further infection. According to the WHO, in 2018, one in five men and one in six women, globally, develop cancer during their lifetime. Moreover, as per reports published by WHO, 18.1 million new cancer cases have been reported in 2018, globally. In addition, as per the WHO, over 70.0% of cancer-related deaths typically occur in middle- and low-income countries. Furthermore, rising prevalence of chronic conditions and growing number of surgeries being performed have also increased globally. Therefore, such factors are anticipated to positively impact growth over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/traditional-wound-management-market

Further key findings from the study suggest:

  • In terms of revenue, acute wounds segment held the largest share in 2018 owing to rising cases of accidents and trauma globally.
  • Gauze segment held the largest share in 2018 owing to its wide range of applicability in various types of wounds and availability of numerous products.
  • Hospital segment held the largest share in 2018 due to rising cases of burns and surgeries.
  • Asia Pacific is expected to witness the fastest growth over the forecast period owing to rising number diabetic patients in this region.
  • Prominent players operating in traditional wound management market are Smith & Nephew PLC, Mölnlycke Health Care, Paul Hartman AG, and Cardinal Health.

Personal Lubricant Market Size Worth $1.6 Billion By 2026

The global personal lubricant market size is expected to reach USD 1.6 billion by 2026, based on a new report by Grand View Research, Inc., exhibiting a CAGR of 8.1%. New product launches to meet demand for natural lubricants is expected to aid market growth over the forecast period.

Emerging players are trying to capture higher share by developing lubricants made from natural and organic ingredients. Good Clean Love, Inc., an Oregon-based company in the U.S., was the first to develop organic lubricants. In November 2016, the company received a patent for its formulation of organic lubricants.

Moreover, promotional activities from manufacturers to destigmatize societal perception of using personal lubricants has positively impacted growth. For instance, in January 2019, Reckitt Benckiser’s Durex brand launched a marketing campaign on a global platform to challenge the misconceptions of using lubricants for female sexual discomfort.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/personal-lubricant-market

Further key findings from the study suggest:

  • Water-based lubricants dominated the market in 2018, owing to lower prices and as they are easy to wash off
  • Leading brands such as Durex, Sliquid, and Astroglide retail a range of water-based lubricants with variations in flavors, pack size, and packaging
  • In July 2018, Trigg Laboratories, Inc. reinvented its entire product line with new packaging and products, which had contemporary, sleek, and modern designs. It also launched a new product line—Wet Hemptation and Wet Dessert
  • The growing presence of e-commerce platforms and online retailers that offer freedom to select any product and make discrete delivery has helped overcome social taboo of buying these products
  • Manufacturers, retail pharmacies, and supermarkets have also launched websites for providing easy access to customers.
  • Geographically, North America held the largest share in 2018. The personal lubricant market is regulated by the U.S. FDA and manufacturers must comply with good manufacturing practices, and receive 510(k) medical device clearance for marketing
  • In May 2016, Trigg Laboratories received FDA approval for Wet Original Personal lubricant by meeting the provisions for labeling, good manufacturing practices and prohibitions against adulteration and misbranding
  • According to U.S. Census data and National Consumer survey, in 2018, K-Y lubricants were used by 28.58 million people, aiding it to capture significant share in the U.S.
  • Asia Pacific is expected to be the fastest growing market during the forecast period. Aging population and high incidence of vaginal dryness & erectile are anticipated to drive demand.

Unified Communications Market Size Worth $167.1 Billion By 2025

The global unified communications market size is expected to reach USD 167.1 billion by 2025, exhibiting a CAGR of 16.8% over the forecast period, according to a new report by Grand View Research, Inc. Changing workforce dynamics, growing prominence for Unified Communication as a Service (UCaaS), and virtualization of data and devices are factors that are expected to increase the adoption of UC solutions in enterprises.

The use of cloud-based solutions for fast and seamless communication across enterprises is expected to positively impact market growth. Organizations are effectively deploying cloud-based collaboration solutions across various time zones so that they can improve the productivity of their mobile team members.

Growing adoption of cloud-based unified communication platforms is allowing geographically-diverse and dispersed teams to work together and collaborate mutually in real-time via voice and video conferencing. The transition toward the cloud is also allowing enterprises to curb capital spending by adopting an operational cost model that will enable them to pay on the basis of the capacity they require.

Increasing demand for UC solutions is opening up opportunities for solution providers to launch advanced versions of team collaboration software for enterprises. Solution providers such as Cisco Systems, Inc.; Avaya, Inc.; and IBM Corporation are offering a mix of UC and team collaboration solutions as part of their efforts to strengthen their market position.

Having realized that there are several UC solutions available in the market, key players are focusing on offering diverse solutions with various features, including support for audio and video conferencing, email platforms, instant messaging, and unified messaging. As a result, the market is expected to witness a convergence of voice communication, video communication, synchronous communication, and other communication tools.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/unified-communication-market

Further key findings from the report suggest:

  • The hosted UC solutions segment is expected to register a significant CAGR over the forecast period owing to increasing implementation of UCaaS solutions in enterprises
  • The healthcare application segment is expected to develop at a CAGR of approximately 20.0% over the forecast period owing to increased adoption of video conferencing tools for remote patient monitoring
  • The SMEs segment is expected to grow at the fastest pace through 2025 owing to the increasing need for an efficient unified infrastructure for improving communication capabilities
  • The audio and video conferencing segment is poised to witness steady growth over the forecast period owing to rising deployment of visual communication tools in enterprises
  • Asia Pacific is expected to be the fastest-growing regional market due to the emergence of local service providers offering diverse solutions
  • Key players in the Unified Communications market include Avaya, Inc.; IBM Corporation; Cisco Systems, Inc.; and NEC Corporation.

Third-party Logistics Market Worth $1.56 Trillion By 2027

The global third-party logistics market size is expected to reach USD 1.56 trillion by 2027, registering a compound annual growth rate (CAGR) of 8.3% from 2020 to 2027, according to a new report by Grand View Research, Inc. The advent of new technologies is changing the Third-party Logistics (3PL) industry dynamics. The advanced data collection capabilities, warehouse automation, and digitalization of the entire supply chain are enabling companies to adopt a consistent innovative, customer-centric, and agile approach. As a result, 3PL companies are providing technologically driven services by investing in block-chain solutions, mobile technologies, and 3PL software to gain a competitive advantage in a fiercely competitive marketplace.

The internet of things (IoT) and cloud-based logistics management solution turn the data into actionable value-added information, which can shape the strategic decision-making process and increase productivity. Some of the capital-intensive organizations are increasing their Information Technology (IT) spending and are using predictive analytics for supply chain enhancement. For instance, C.H. Robinson Worldwide (CHRW) Inc. is using artificial intelligence (AI) technology to analyze the customer data and get notified about extreme weather conditions or traffic disruption.

Logistics automation is expected to play a vital role in the growth of the third-party logistics market. The use of robots in warehouses and unloading docks help to streamline order fulfillment services. The use of automated guided vehicle (AGV) can help to lessen the human errors, resolve material handling issues, ensure movement of high-volume goods, and increase accuracy and repeatability. In order to deliver immediate value and long-term returns, companies are widely accepting logistics automation.

The value-added logistics services are expected to witness the highest growth rate over the forecast period. The 3PL companies are offering comprehensive logistics services to ensure their competitiveness of the business. Shippers are reducing their operational costs by shifting their focus from transportation and back-office functions such as warehousing, order taking and picking process, kitting and final assembly, product localization, and labeling. Thus, the value-added logistics services are becoming the boon for the shippers to mitigate inventory and transportation costs.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/third-party-logistics-market

Further key findings from the study suggest:

  • The 3PL companies are emphasizing value-added logistics services to unveil their unique capabilities and provide enhanced customer experience, facilitating the strong growth of the segment
  • Logistics is the backbone of the retail sector. The steady growth of the sector is expected to provide lucrative opportunities for 3PL companies
  • Globalization, along with sustainable economic growth, is expected to drive the growth of airways logistics mode over the forecast period
  • Asia Pacific is anticipated to register the highest CAGR of over 10.0% from 2020 to 2027 owing to the growing transport infrastructure and effective transit of freight and goods among emerging countries

Construction Equipment Market Size Worth $173.0 Billion By 2027

The global construction equipment market size is expected to reach USD 173.0 billion by 2027, expanding at a CAGR of 4.3% over the forecast period, according to a new report by Grand View Research, Inc. Rising construction activities, technological development, automation, and increased importance for incorporating safety features are expected to drive the market. The prominent manufacturers have an increased focus on product development and have identified it as the key strategy to achieve sustainable market progress. The companies have recognized the market shift toward electric mobility and a sustainable future. For instance, in December 2019, Hitachi Construction Machinery Co., Ltd. announced the development of a battery-powered mini excavator.

The demand had earlier witnessed a slowdown owing to sluggish growth of the construction industry and economic conditions. However, the market is expected to grow at a steady growth rate in the upcoming years. The prominent factors contributing to the market growth are growing residential, commercial, and industrial construction activities and increasing private-public partnerships. Customers now prefer renting the equipment rather than spending money on buying them, thus helping them save investments on procurement and maintenance of the equipment. Many companies are entering in the equipment rental business owing to its high profitability. However, in terms of large-scale projects that are time-intensive, the purchase of machinery proves beneficial.

The earthmoving machinery segment accounted for the highest market share of around 64% in 2019. Increasing demand for this equipment from developing countries is driving the growth of this segment. China is considered as a leader in the earthmoving machinery segment. The country faced weak economic conditions in 2019, thus the government actively implemented measures such as tax cuts and boosted the funding for infrastructure activities. These factors acted favorably in securing the market demand for various types of equipment. However, the recent coronavirus outbreak is projected to hamper the growth prospects owing to slow down in production and supply chain problems.

The North American construction equipment market is anticipated to perform positively in 2020, owing to the U.S. government’s keen focus on enhancing the transportation infrastructure. According to the American Road & Transportation Builders Association (ARTBA), the construction activity for parking lots, private highways, driveways, and bridges is estimated to reach a value of approximately USD 72 billion in 2020 and is projected to grow over the next five years. Thus, the development in construction activities is anticipated to drive the market growth in U.S. over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/construction-equipment-market-analysis

Further key findings from the report suggest:

  • Earth moving machinery emerged as the largest product segment in 2019 and is anticipated to reach more than USD 104.0 billion by 2027
  • The concrete and road construction machinery segment is expected to register a CAGR of 6.2% over the forecast period
  • The Asia Pacific region dominated the market in 2019 and is anticipated to expand at a CAGR of 4.9% over the forecast period
  • The market is highly competitive and relatively concentrated, with the top five companies dominating the market share
  • The top five key players in the construction equipment market are Caterpillar Inc.; Komatsu; Hitachi Construction Machinery; Liebherr; and Volvo construction equipment

Intelligent Transportation System Market Worth $37.64 Billion By 2027

The global intelligent transportation system market size is expected to reach USD 37.64 billion by 2027, exhibiting a CAGR of 5.8% over the forecast period, according to a study conducted by Grand View Research, Inc. Necessity to reduce traffic congestion and improve road safety and security, implementation of data analytics and cloud computing in traffic management systems, and cost-effectiveness of intelligent transportation systems is projected to fuel the market growth.

Rapidly changing consumer demand has subsequently posed new challenges for manufacturers and retailers. Consumers are particularly demanding for reliability and efficiency, same-day deliveries, and real-time shipment tracking facilities. Timely delivery owing to reduce in-transit time and tracking facility are some of the features that are particularly in demand. Provisioning these features would require a comprehensive transportation management system capable enough of bridging the gap between order management and warehouse fulfillment. As a result, ITS vendors are introducing the latest solutions that can effectively meet the challenges posed by the growth of the e-commerce industry and the changing consumer behavior.

In addition to being one of the leading causes of accidents, lack of road safety also results in high costs and adversely impacts the overall economic development. Numerous initiatives are being undertaken to install technologically advanced traffic management systems and overall awareness about the importance of road security and safety. This is expected to result in the demand for Vehicle-to-Vehicle (V2V) and Vehicle to Infrastructure (V2I) over the forecast period. Developed markets of Europe and North America have mandated the use of Electronic Stability control (ESC) systems, a driver assistance system, and in passenger as well as commercial vehicles. This is expected to favorably impact the overall demand for intelligent transportation system over the forecast period.

Moreover, in 2020, the ITS market will be hampered due to the COVID-19 crisis, which has impacted demand, interrupted production, and disrupted supply chain. Thus, various market players are experiencing flat or lower unit sales. However, with economic stimulus packages announced by many countries such as Japan, U.S., China, France, Italy, India, U.K., and Germany, is anticipated to create great opportunities for transportation infrastructure development.

North America ITS market dominated in 2019 and is projected to continue its dominance over the foreseen years. The U.S. alone holds more than 75% of the market share in North America. The U.S. government has developed a national architecture that offers guidance to private companies and urban areas likely to implement an intelligent transportation system of what functions and communication technologies are essential to be compatible with other systems. This architecture is specifically aimed at providing interoperability for ITS across U.S. Moreover, strong government support, R&D activities, and strategic public-private partnerships aimed at improving the transportation network across the region are some major factors fueling the growth of the market for intelligent transportation system.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/intelligent-transportation-systems-industry

Further key findings from the study suggest:

  • The Advanced Traffic Management System segment is expected to dominate the ITS market owing to it helps in detecting dangerous weather conditions, roadway hazards, accidents, and creates a complete integrated view of overall traffic flow. The segment is expected to reach USD 12.16 billion by 2027
  • The traffic management market is expected to dominate the application segment and the trend is expected to continue over the forecast period. It is anticipated to reach USD 12.07 billion by 2027. Traffic management systems help enhance operational performance and reliability of road networks
  • North America is projected to account for the majority share of the market over the forecast period. Advancements in communication technologies are boosting the revolution of the transportation network in U.S. The region is anticipated to reach USD 14.33 billion by 2027

Asia Pacific Drug Development Market Worth $62.46 Billion By 2026

The Asia Pacific drug development market is expected to reach USD 62.46 billion by 2026 and is projected to expand at a CAGR of 6.54%, according to a new report by Grand View Research, Inc. Challenges pertaining to the escalating research costs and shrinking revenue faced by major pharma companies have led to the significant expansion of Asian drug development sector. A rapidly expanding healthcare infrastructure, low operating costs, and a growing patient population have contributed to the recognition of Asian countries as an ideal site for low-cost drug development.

Young attractive female scientist holding a red transparent pill with futuristic scientific air interface with chemical formulas and research data in the foreground

Furthermore, the growing acceptance of clinical trial data generated in Asia by Western drug regulators, including the EMA and U.S. FDA, is one of the key market drivers. This is primarily because of the increasing similarities of Asian disease demographics to that of the Western nations.

Various government policies have been formulated to promote implementation of digital and advanced analytics, such as artificial intelligence, in the region. Moreover, the pharma companies are collaborating with AI-based companies to leverage algorithms and cloud computing to transform their drug development process.

The contract research organizations are experiencing increasing levels of interest in Asian countries from their U.S. –based client base. This is a testament to the lucrative growth of Asia Pacific market, driving its growth in the coming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/asia-pacific-drug-development-market

Further key findings from the report suggest:

  • Outsourced mode of pharmaceutical development led the market and is expected to maintain its dominance throughout the forecast period, due to the fact that the companies are investing or redirecting their significant investments from already existing R&D centers in Europe and U.S. to emerging centers in Asia
  • Analytical & stability studies captured the largest revenue share in the market, due to the high usage of advanced and relative expensive technologies such as Electron Paramagnetic Resonance (EPR) spectroscopy
  • Oncology is estimated to be the highest revenue generating segment, due to the presence of a substantial number of cancer targeting therapeutics in clinical development phase. This segment is expected to maintain a fast CAGR during the forecast period owing to wide acceptance of personalized therapy in cancer treatment
  • Strong government support for innovation and large and diverse domestic pharma industry of China has led to the dominance of China over other countries in the Asia Pacific drug development market
  • Furthermore, the launch of several start-ups in India is expected to serve as a significant source of revenue to the Indian pharmaceutical industry
  • Some key contract service providers operating in the Asia Pacific drug development market are Eurofins Advinus; Covance Inc.; Celerion; and Parexel International Corporation. With the rising trend of outsourcing pharmaceutical manufacturing, these CROs are expected to witness great organic revenue growth
  • In house global pharmaceutical manufacturers such as Pfizer and AstraZeneca are also striving to gain competitive ground in the Asian market

Advanced Bipolar Direct Energy Devices Market Worth $3.3 Billion By 2026

The global advanced bipolar direct energy devices market size is anticipated to reach USD 3.3 billion by 2026 registering a CAGR of 14.2%, according to a new report by Grand View Research, Inc. Increasing adoption of bipolar electrosurgical systems over conventional devices and high demand for laparoscopic surgeries are anticipated to boost the market growth.

These systems are mostly used to coagulate, cutting, fulguration, and desiccate soft tissues through generating heat by an electric current. The product demand has been increasing owing to its benefits in surgical procedures, such as lower risk of hemorrhaging than conventional devices that focus on scalpels. In addition, conventional equipment are costlier, which is also driving the demand for advanced bipolar direct energy systems for improved safety in desiccating soft tissues.

Technological advancements in the field are further expected to augment the market growth. For instance, XCELLANCE Medical Technologies launched a new 6-sense technology designed for cutting tissues at lower voltages by sensing voltage and power. This technology minimizes the patient recovery time and is a versatile tool for hemostatic dissection in performing surgical procedure.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/advanced-bipolar-direct-energy-devices-market

Further key findings from the report suggest:

  • Electrosurgical generator systems led the global market in 2018. The segment is projected to expand further at the fastest CAGR from 2019 to 2026
  • Hospital was the dominant end use segment in 2018 owing to increased number of laparoscopic surgical procedures for tissue coagulation performed in these healthcare settings
  • North America led the global advanced bipolar direct energy devices market in 2018. However, Asia Pacific is estimated to be the fastest-growing regional market over the forecast period
  • Some of the key companies in this market are Bovie Medical Corp., Medtronic PLC, B. Braun Melsungen AG, XCELLANCE Medical Technologies Pvt. Ltd., Olympus Corp., and Karl Storz
  • These companies focus on technological advancements to gain competitive advantage. Medtronic launched Aquamantys bipolar sealers designed by transcollation technology, which combines Radiofrequency (RF) energy and saline to provide hemostatic sealing of soft tissues

Scleroderma Therapeutics Market Size Worth $2.6 Billion By 2026

The global scleroderma therapeutics market size is expected to reach over USD 2.6 billion by 2026 registering a CAGR of 6.0%, according to a new study by Grand View Research, Inc. The market growth is credited to the availability of various therapies used off-label, such as small molecule therapies including branded, generics, and OTC drugs.

The mix of several indications and drug classes engenders a fragmented market with multiple players. Roche is the dominant company with biologic immunosuppressants, Actemra/RoActemra, Cellcept, and Rituxan contributing majorly to the company’s share. Pfizer and Eli Lilly are the key companies in the market. Over the forecast period, new entrants including Boehringer Ingelheim, Corbus Pharmaceuticals, and Fibrocell will marginally displace the share of established firms in this market.

The on-label market is in the development phase. Supplemental indication approval is one of the most common strategies adopted by market participants. For example, riociguat by Bayer was previously used for PAH and currently, it is under clinical trials for the treatment of SSc-related digital ulcers. There are several other pharmaceutical companies following suit as this strategy favors the pharmaceutical industry in offsetting high development costs and in reaping larger benefits from one molecule already developed and present in the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/scleroderma-therapeutics-market

Further key findings from the study suggest:

  • The immunosuppressants segment held the largest market share in 2018 and is likely to maintain the dominance throughout the forecast years
  • High preference for immunosuppressants owing to the favorable reimbursement scenario associated with this drug class supports its dominant market share
  • Systemic scleroderma indication segment accounted for the major market share and will expand further due to use of high-priced immunosuppressants
  • U.S. held the majority of the share in 2018. Expected label expansions and expected launch of first-in-class therapies coupled with an evolving reimbursement landscape for orphan drugs support continual scleroderma therapeutics market growth
  • Europe trails with a lower share as compared to the U.S. majorly due to higher use of generics and biosimilars for off-label treatment of scleroderma
  • Some of the key companies are F. Hoffman La-Roche Ltd.; Bristol-Myers Squibb Company; Celgene Corp.; arGentis Pharmaceuticals, LLC; Bayer AG; Boehringer Ingelheim International GmbH; Akashi Therapeutics; Prometic Life Sciences, Inc.; Emerald Health Pharmaceuticals; Kadmon Holdings, Inc.; Seattle Genetics, Inc.; Cytori Therapeutics, Inc.; Fibrocell Science, Inc.; Chemomab; Corbus Pharmaceuticals Holdings, Inc.; and Genkyotex SA